Aakaar Medical Technologies Limited
Bookbuilding IPO · NSE
- Price band
- ₹68 - ₹72
- Lot size
- 1,600 shares
- Issue amount
- ₹27 cr
- Total subscription
- 2.25×
- Opens
- 20 Jun 2025
- Closes
- 24 Jun 2025
- Allotment
- 25 Jun 2025
- Listing
- 27 Jun 2025
Offer at a glance
Issue overview
- Issue size
- 37,50,400 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,08,800
- Fresh issue
- ₹27 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,15,200
- Issue type
- Bookbuilding IPO
- Shares before issue
- 1,04,22,416
- Shares after issue
- 1,41,72,816
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,600 | ₹1,15,200 |
| HNI | 2 | 3,200 | ₹2,30,400 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | — | 7 |
| NIB | — | 123 |
| RETAIL | — | 1,507 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 5.13 | 17.97 |
| RETAIL | 8.99 | 17.36 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 6.13 | 3.14 | 2.36 |
| ROE | 0 | 0 | 0 |
| ROCE | 21.02 | 17.68 | 22.3 |
| RONW | 33.81 | 25.88 | 24.35 |
| PRE IPO(PE) | 12.43 | 0 | 0 |
| POST IPO(PE) | 16.9 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Aakaar Medical Technologies Limited, established in June 2013, is a company focused on aesthetic medical solutions, offering a wide range of specialized cosmetic products and devices. It primarily caters to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists. The company provides both its own brands—comprising products made in India and devices produced internationally—as well as imported brands from countries like South Korea, Spain, Italy, and Austria. These products are mainly supplied to professionals who either use them during treatments or sell them to end users. Aakaar’s offerings include skincare for home and professional use, injectable and contouring products, hair care solutions such as growth serums and tablets, medifacial kits, and various medical devices. These devices are used for treatments like urinary incontinence, tattoo removal, skin rejuvenation, laser hair reduction, and hair transplants. With a presence across India, the company has a strong network of 90 trained sales and service engineers, supporting a large and satisfied customer base. It distributes its products in multiple states including Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.
Strengths
- Strong and Experienced Leadership: Managed by industry experts with deep domain knowledge in aesthetic medicine, driving strategic growth and operational excellence.
- Diversified Product Portfolio: Offers a comprehensive range of aesthetic devices and consumables, including both in-house and imported brands, catering to varied customer needs.
- Extensive Geographic Footprint: Maintains a robust pan-India presence through direct branches and an established consignment partner network, ensuring broad market coverage and accessibility.
Risk factors
- High Dependence on Imported Products: Significant reliance on third-party international brands makes the company vulnerable to supply chain interruptions, import delays, and foreign market uncertainties.
- Reliance on Contract Manufacturers: Heavy dependence on external manufacturing partners and loan license arrangements increases exposure to risks around production consistency, quality assurance, and regulatory compliance.
- Exposure to Cost Fluctuations: Volatile prices of raw materials, utilities, and logistics may adversely affect margins, operational efficiency, and overall financial performance.
Promoters
Dilip Ramesh Meswani
Bindi Dilip Meswani
Registrar & documents
Lead manager
Indorient Financial Services Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
801, Heritage Plaza, Telli Galli Cross Road Andheri (East), Mumbai, Maharashtra, 400069
+91 84528 44024
[email protected]Company website ↗Understanding AAKAAR IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.